Enhancing pharmacological and behavioural support to reduce smoking relapse: A factorial RCT

加强药物和行为支持以减少吸烟复吸：析因随机对照试验

• 批准号: nhmrc : GNT1095880
• 负责人: A/Pr Coral Gartner
• 金额: $ 91.32万
• 依托单位国家: 澳大利亚
• 项目类别: International Collaborations
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/enhancing-pharmacological-behavioural-factorial-rct/1345963
• 关键词: Enhancing; pharmacological; behavioural; support; reduce

Typically stop smoking services users use a base medicine for 8-12 weeks complemented by counselling, delivered via telephone in Australia. This is effective at helping people stop smoking in the short-term, but after one year most will have relapsed. Effective strategies to prevent smoking relapse are desperately needed. The use of stop smoking medicines beyond 8-12 weeks can help reduce relapse, but research (ours and others), find uptake to be modest. New products that deliver nicotine in va

在澳大利亚，戒烟服务使用者通常会使用基础药物 8-12 周，并辅以通过电话提供的咨询服务。这可以有效帮助人们在短期内戒烟，但一年后大多数人都会复吸。迫切需要有效的策略来防止复吸。使用戒烟药物超过 8-12 周可以帮助减少复发，但研究（我们的和其他人的）发现，使用率很低。在VA中提供尼古丁的新产品